Clinical pharmacologic aspects of cytochrome P-450 dependent biotransformation of drugs
Ackermann, E.
Die Pharmazie 33(7): 400-406
1978
ISSN/ISBN: 0031-7144 PMID: 364493 Document Number: 132395
Document emailed within 1 workday
Related Documents
Ortweiler, W.; Peiker, G.; Siegert, C.; Splinter, F.K.; Traeger, A. 1987: The effect of intrahepatic cholestasis in pregnancy on various forms of cytochrome P-450-dependent biotransformation reactions Die Pharmazie 42(5): 329-331Costa, F.V. 1988: Clinical pharmacologic aspects of mepartricin. Possible pharmacologic interference with digitaloids and anticoagulants Minerva Urologica e Nefrologica 40(2 Suppl): 5-6
Rohde, K.; Blanck, J.; Ruckpaul, K. 1983: Kinetics of elementary steps in the cytochrome P-450 reaction sequence. VI. Model treatment of the NADPH-dependent first electron transfer reaction between cytochrome P-450 reductase and cytochrome P-450 LM2 in solution Biomedica Biochimica Acta 42(6): 651-662
Sattler, M.; Guengerich, F.P.; Yun, C.H.; Christians, U.; Sewing, K.F. 1992: Cytochrome P-450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat Drug Metabolism and Disposition: the Biological Fate of Chemicals 20(5): 753-761
Keyes, S.R.; Fracasso, P.M.; Heimbrook, D.C.; Rockwell, S.; Sligar, S.G.; Sartorelli, A.C. 1984: Role of NADPH:cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C1 Cancer Research 44(12 Pt 1): 5638-5643
Vickers, A.E.; Meyer, E.; Dannecker, R.; Keller, B.; Tynes, R.E.; Maurer, G. 1995: Human liver cytochrome P4503A biotransformation of the cyclosporin derivative SDZ IMM 125 Drug Metabolism and Disposition: the Biological Fate of Chemicals 23(3): 321-326
Lingjaerde, O. 1972: Lithium. Pharmacologic, clinical and therapeutic aspects Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 92(30): 1998-2002
Iwata, H. 1993: Pharmacologic and clinical aspects of intraarticular injection of hyaluronate Clinical Orthopaedics and Related Research 289: 285-291
Brøsen, K. 1991: The significance of cytochrome P450 gene superfamily for the clinical pharmacokinetics of drugs Ugeskrift for Laeger 153(6): 417-422
Devoize, J.L.; Rigal, F.; Eschalier, A.; d'Ambrosio, A. 1984: Clinical and pharmacologic aspects of the analgesic effect of tricyclic antidepressants Presse Medicale 13(46): 2806-2809
Carella, G. 1984: Antagonists of histamine H1 and H2 receptors: pharmacologic aspects and clinical significance La Clinica Terapeutica 110(4): 375-379
Pinto, A.; Abraham, N.G.; Mullane, K.M. 1987: Arachidonic acid-induced endothelial-dependent relaxations of canine coronary arteries: contribution of a cytochrome P-450-dependent pathway Journal of Pharmacology and Experimental Therapeutics 240(3): 856-863
Cresteil, T.; Monsarrat, B.; Alvinerie, P.; Tréluyer, J.M.; Vieira, I.; Wright, M. 1994: Taxol metabolism by human liver microsomes: identification of cytochrome P450 isozymes involved in its biotransformation Cancer Research 54(2): 386-392
Campbell, M.E.; Grant, D.M.; Inaba, T.; Kalow, W. 1987: Biotransformation of caffeine, paraxanthine, theophylline, and theobromine by polycyclic aromatic hydrocarbon-inducible cytochrome(s) P-450 in human liver microsomes Drug Metabolism and Disposition: the Biological Fate of Chemicals 15(2): 237-249
Domínguez de Villota, E.; Shubin, H.; Liu, V.Y.; Weil, M.H. 1983: Severe poisoning with barbiturates, glutethimide and other sedative drugs. (I) Clinical aspects, mortality and therapeutic aspects of 68 patients Revista Clinica Espanola 171(6): 409-413
Auer, J.; Berent, R.; Weber, T.; Porodko, M.; Mayr, H.; Maurer, E.; Eber, B. 2001: Pharmacologic interventions in primary prevention: lipid lowering drugs, aspirin, antiobesity drugs, and antihypertensive agents Wiener Medizinische Wochenschrift 151(1-2): 13-17
Gillette, J.R.; Hinson, J.A. 1978: Biotransformation of drugs Advances in Experimental Medicine and Biology 97: 5-25
Gillette, J.R. 1979: Biotransformation of drugs during aging Federation Proceedings 38(5): 1900-1909
Bao, J.; Sauer, J.M.; Smith, R.L.; Kuester, R.K.; Kattnig, M.J.; Sipes, I.G. 1998: Sulfhydryl-dependent biotransformation and macromolecular binding of 1,2-dibromo-2,4-dicyanobutane in blood Drug Metabolism and Disposition: the Biological Fate of Chemicals 26(10): 1001-1007
Akimov, V.G.; Omel'chenko, O.G.; Lashmanova, A.P. 1985: Deliberate change of the rate of biotransformation of drugs Vestnik Dermatologii i Venerologii 7: 18-20